6MaaikeLuesink,Joop H.Jansen.Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia[J]. British Journal of Haematology . 2010 (3)
8V Mathews,S Desire,B George,K M Lakshmi,J G Rao,A Viswabandya,A Bajel,V M Srivastava,A Srivastava,M Chandy.Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity. Leukemia . 2006
9Haverkamp W,Breithardt G,Camm A J,Janse M J,Rosen M R,Antzelevitch C,Escande D,Franz M,Malik M,Moss A,Shah R.The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovascular Research . 2000
10Jones Robin L,Ewer Michael S.Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs. Expert review of anticancer therapy . 2006
